Mutations in katG, inhA and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis

被引:91
作者
Silva, MSN
Senna, SG
Ribeiro, MO
Valim, ARM
Telles, MA
Kritski, A
Morlock, GP
Cooksey, RC
Zaha, A
Rossetti, MLR
机构
[1] Fundacao Estadual Prod & Pesquisa Saude, CDCT, Lab Cent Saude Publ, BR-90610000 Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil
[3] Univ Fed Rio Grande Sul, Dept Biol Mol & Biotecnol, Porto Alegre, RS, Brazil
[4] Inst Adolfo Lutz Registro, Setor Micobacterias, Sao Paulo, Brazil
[5] Univ Fed Rio de Janeiro, Hosp Clementino Fraga Filho, Inst Doencas Torax, Rio De Janeiro, Brazil
[6] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div AIDS STD & TB Lab Res, Atlanta, GA USA
关键词
D O I
10.1128/JCM.41.9.4471-4474.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The presence of mutations in specific regions of the katG, inhA, and ahpC genes was analyzed with 69 Mycobacterium tuberculosis isoniazid-resistant isolates from three Brazilian states. Point mutations in codon 315 of the katG gene were observed in 87.1, 60.9, and 60% of the isolates from Rio Grande do Sul, Rio de Janeiro, and Sao Paulo, respectively. Mutations in the inhA gene were identified only in one isolate from RJ State, and the ahpC promoter region revealed mutations in distinct positions in 12.9, 21.7, and 6.7% of the isolates from RS, RJ and SP, respectively.
引用
收藏
页码:4471 / 4474
页数:4
相关论文
共 29 条
[1]   Variations in the occurrence of the S315T mutation within the katG gene in isoniazid-resistant clinical Mycobacterium tuberculosis isolates from Kuwait [J].
Abal, AT ;
Ahmad, S ;
Mokaddas, E .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 2002, 8 (02) :99-105
[2]   Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG [J].
Abate G. ;
Hoffner S.E. ;
Miörner H. .
European Journal of Clinical Microbiology and Infectious Diseases, 2001, 20 (5) :329-333
[3]   INHA, A GENE ENCODING A TARGET FOR ISONIAZID AND ETHIONAMIDE IN MYCOBACTERIUM-TUBERCULOSIS [J].
BANERJEE, A ;
DUBNAU, E ;
QUEMARD, A ;
BALASUBRAMANIAN, V ;
UM, KS ;
WILSON, T ;
COLLINS, D ;
DELISLE, G ;
JACOBS, WR .
SCIENCE, 1994, 263 (5144) :227-230
[4]  
CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21
[5]  
Cormand B, 1997, AM J MED GENET, V70, P437, DOI 10.1002/(SICI)1096-8628(19970627)70:4<437::AID-AJMG19>3.0.CO
[6]  
2-I
[7]   Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland (1990 to 1997) [J].
Fang, Z ;
Doig, C ;
Rayner, A ;
Kenna, DT ;
Watt, B ;
Forbes, KJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (04) :998-1003
[8]   Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa [J].
Haas, WH ;
Schilke, K ;
Brand, J ;
Amthor, B ;
Weyer, K ;
Fourie, PB ;
Bretzel, G ;
StichtGroh, V ;
Bremer, HJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) :1601-1603
[9]   Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis [J].
Kelley, CL ;
Rouse, DA ;
Morris, SL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) :2057-2058
[10]  
KUDOH S, 1974, B WORLD HEALTH ORGAN, V51, P71